In vitro binding and CNS effects of novel neurotensin agonists that cross the blood-brain barrier. (Q48148694)

9 February 2018

title

In vitro binding and CNS effects of novel neurotensin agonists that cross the blood-brain barrier. (English)

1 reference

9 February 2018

1 reference

4

1 reference

9 February 2018

author name string

Tyler BM

1

1 reference

9 February 2018

Douglas CL

2

1 reference

9 February 2018

Fauq A

3

1 reference

9 February 2018

Stewart JA

5

1 reference

9 February 2018

Cusack B

6

1 reference

9 February 2018

McCormick DJ

7

1 reference

9 February 2018

Richelson E

8

1 reference

9 February 2018

publication date

1 July 1999

1 reference

9 February 2018

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Neuropharmacology

1 reference

9 February 2018

volume

38

1 reference

9 February 2018

issue

7

1 reference

9 February 2018

page(s)

1027-1034

1 reference

9 February 2018

Structure-antinociceptive activity of neurotensin and some novel analogues in the periaqueductal gray region of the brainstem.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900011-8

Permeability of the blood-brain barrier to the neurotensin8-13 analog NT1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900011-8

Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900011-8

Haloperidol but not clozapine increases neurotensin receptor mRNA levels in rat substantia nigra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900011-8

Neurotensin administered intracisternally inhibits responsiveness of mice to noxious stimuli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900011-8

Neurotensin: Antinocisponsive action in rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900011-8

Pharmacological and biochemical profiles of unique neurotensin 8-13 analogs exhibiting species selectivity, stereoselectivity, and superagonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900011-8

A method for radioligand binding assays using a robotic workstation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900011-8

Repeated neurotensin administration in the ventral tegmental area: effects on baseline and D-amphetamine-induced locomotor activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900011-8

Rapid degradation of neurotensin by intact murine neuroblastoma cells (clone N1E-115)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900011-8

Specific binding of tritiated neurotensin to rat brain membranes: characterization and regional distribution.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900011-8

Atypical neuroleptic-like behavioral effects of neurotensin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900011-8

Neurotensin selectively antagonizes apomorphine-induced stereotyped climbing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900011-8

[3H]neurotensin(8-13) binds in human brain to the same sites as does [3H]neurotensin but with higher affinity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900011-8

The neurobiology of neurotensin: focus on neurotensin-dopamine interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900011-8

[3H]Neurotensin receptor densities in human postmortem brain tissue obtained from normal and schizophrenic persons. An autoradiographic study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900011-8

Pharmacokinetics of novel hexapeptides with neurotensin activity in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900011-8

Differential effects of haloperidol and clozapine on neurotensin gene transcription in rat neostriatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900011-8

Distribution of neurotensin binding sites in rat brain: a light microscopic radioautographic study using monoiodo [125I]Tyr3-neurotensin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900011-8

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900011-8

Proposed ligand binding site of the transmembrane receptor for neurotensin(8-13).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900011-8

Preparation of neurotensin selectively iodinated on the tyrosine 3 residue. Biological activity and binding properties on mammalian neurotensin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900011-8

CSF neurotensin concentrations and antipsychotic treatment in schizophrenia and schizoaffective disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900011-8

Evidence for additional neurotensin receptor subtypes: neurotensin analogs that distinguish between neurotensin-mediated hypothermia and antinociception.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900011-8

Specific gene blockade shows that peptide nucleic acids readily enter neuronal cells in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900011-8

CNS drug design based on principles of blood-brain barrier transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900011-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0028-3908(99)00011-8

1 reference

9 February 2018

PubMed ID

10428421

1 reference

9 February 2018